dianhydro-3,4-diacetylgalactitol has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, W; Li, M; Lian Yan, X; Rong Cui, J; Xu, B; Zhang, XY; Zhou, Y | 1 |
| Cao, LZ; Lai, XJ; Lan, XW; Liao, ZH; Zhou, SF; Zhou, Y | 1 |
2 other study(ies) available for dianhydro-3,4-diacetylgalactitol and Cancer of Liver
| Article | Year |
|---|---|
Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dianhydrogalactitol; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Nude; Up-Regulation; Xenograft Model Antitumor Assays | 2009 |
[Apoptosis of hepatocarcinoma cell line HLE induced by the combination of wild type P53 gene and 1,2:5,6-dianhydro-3,4-diacetylgalactitol].
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Dianhydrogalactitol; Genes, p53; Humans; Liver Neoplasms; Transfection | 2004 |